Restaurants Canada says supply of Temporary Foreign Works represents only a small but critical percentage of the total workforce

Toronto, Sept. 03, 2025 (GLOBE NEWSWIRE) — In response to the Leader of the Official Opposition's calls today to scrap the Temporary Foreign Worker program, Restaurants Canada says without enough staff for key roles, restaurants in rural and remote communities risk reduced hours, closures, and lost local jobs. Temporary Foreign Workers (TFWs), while making up […]

Restaurants Canada says supply of Temporary Foreign Works represents only a small but critical percentage of the total workforce

Restaurants Canada says supply of Temporary Foreign Works represents only a small but critical percentage of the total workforce GlobeNewswire September 03, 2025 Toronto, Sept. 03, 2025 (GLOBE NEWSWIRE) — In response to the Leader of the Official Opposition's calls today to scrap the Temporary Foreign Worker program, Restaurants Canada says without enough staff for

Replimune (REPL) Faces Investor Lawsuit After FDA Blocks Cancer Drug Approval – Hagens Berman

Replimune Group Inc. (NASDAQ: REPL) is under fire from investors following a dramatic regulatory setback that sent its stock into freefall. A newly filed securities class action accuses the biotech firm and its leadership of concealing critical risks tied to its flagship cancer therapy, RP1, and overstating the strength of clinical trial data used to

Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2

(NasdaqGM:TVGN),(NASDAQ:TVGNW), WARREN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the continuing need for SARS-CoV-2 treatments for individuals with weakened immune systems, who are at the highest risk of complications from the virus. TVGN 489, the Company's investigational allogeneic SARS-CoV-2-specific Cytotoxic CD8+ T lymphocyte (CTL)

Surrozen to Present at Upcoming Healthcare Investor Conference

(NASDAQ:SRZN), SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye diseases, today announced that Company management will present at an upcoming healthcare investor conference. H.C. Wainwright 27th Annual

AMH to Participate in BofA Securities 2025 Global Real Estate Conference

AMH (NYSE: AMH), a leading large-scale integrated owner, operator, and developer of single-family rental homes, today announced that members of the Company's management team will participate in a roundtable discussion at the BofA Securities 2025 Global Real Estate Conference on Wednesday, September 10, 2025 at 9:35 a.m. Eastern Time. https://mma.prnewswire.com/media/1990748/AMH_Logo.jpg A live audio webcast of

Construction Partners, Inc. to Host 2025 Analyst Day and Hot-Mix Asphalt Facility Tour on October 22, 2025

Construction Partners, Inc. (NASDAQ: ROAD) (“CPI” or the “Company”), a vertically integrated civil infrastructure company specializing in the construction and maintenance of roadways in local markets throughout the Sunbelt, today announced that it will host an in-person 2025 Analyst Day and hot-mix asphalt facility tour with financial analysts and institutional investors on Wednesday, October 22,

Surrozen to Present at Upcoming Healthcare Investor Conference

Surrozen to Present at Upcoming Healthcare Investor Conference GlobeNewswire September 03, 2025 SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye diseases, today announced that Company management will

Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2

Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2 GlobeNewswire September 03, 2025 WARREN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the continuing need for SARS-CoV-2 treatments for individuals with weakened immune systems, who are at the

Nasdaq Reports August 2025 Volumes

(NASDAQ:NDAQ), NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for August 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. About NasdaqNasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators

Scroll to Top